MariMed Inc.
MRMD
$0.08
$0.00-1.27%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.17% | 2.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.17% | 2.91% | |||
| Cost of Revenue | 27.65% | 3.49% | |||
| Gross Profit | -35.82% | 2.06% | |||
| SG&A Expenses | 2.18% | -0.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.11% | 1.80% | |||
| Operating Income | -354.30% | 36.25% | |||
| Income Before Tax | -3,926.37% | 68.57% | |||
| Income Tax Expenses | -197.39% | 299.28% | |||
| Earnings from Continuing Operations | -57.80% | -131.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 242.86% | -800.00% | |||
| Net Income | -57.09% | -132.31% | |||
| EBIT | -354.30% | 36.25% | |||
| EBITDA | -134.26% | 3.90% | |||
| EPS Basic | -56.00% | -127.27% | |||
| Normalized Basic EPS | -10,400.00% | 85.71% | |||
| EPS Diluted | -17.00% | -203.03% | |||
| Normalized Diluted EPS | -10,400.00% | 85.71% | |||
| Average Basic Shares Outstanding | 0.68% | 0.70% | |||
| Average Diluted Shares Outstanding | 0.68% | 0.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||